New Alzheimer's-Targeting drug safety study halted before it began
NCT ID NCT07155980
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 30 times
Summary
This study was designed to test the safety of an experimental drug called GSM-779690T in healthy adults. It was a first-in-human trial, meaning the drug had never been given to people before. The goal was to see if it was safe and how it affected certain proteins in the brain linked to Alzheimer's disease. However, the study was withdrawn before any participants were enrolled.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT PARTICIPANTS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Worldwide Clinical Trials
San Antonio, Texas, 78217, United States
Conditions
Explore the condition pages connected to this study.